非洲裔美国甲状腺癌患者中推测致病性胚系与体细胞变异
研究对接受癌症中心治疗的37例非洲裔美国非髓样甲状腺癌患者进行全外显子测序,分析胚系和体细胞推测致病性变异(PPGV/PPSV)与临床结局的关系。在16个癌症易感或已知癌症相关基因中鉴定出17个PPGV,仅WRN既往已知与NMTC易感相关;BRAFV600E是最常见的PPSV,见于29例肿瘤中的12例(41%)。作者认为该队列多数患者治疗后结局良好,提示医疗保健差异是预后较差的主要因素。
要点
- 在16个癌症易感或已知癌症相关基因中鉴定出17个PPGV,仅WRN既往已知与NMTC易感相关。
- BRAFV600E是最常见的PPSV,在29例肿瘤中检出12例(41%)。
- 作者认为该队列多数患者治疗后结局良好,提示医疗保健差异是预后较差的主要因素。
核心结论
- 在该队列中,多数非洲裔美国非髓样甲状腺癌患者在接受癌症中心治疗性干预后结局良好,提示医疗保健差异是非洲裔美国非髓样甲状腺癌患者预后较差的主要因素。
- 可能促进TP53肿瘤突变获得的PPGV和/或易感不良心血管事件的PPGV的临床影响需进一步探索,后者可能因治疗所致心脏毒性而加重。
- 对不同疾病阶段非髓样甲状腺癌患者的PPGV/PPSV谱进行整合分析,可能有助于识别需要密切监测或积极干预的患者。
研究设计与样本
- 对37例和29例非洲裔美国非髓样甲状腺癌患者分别采集的血液/正常组织DNA(N=37)和配对肿瘤样本(N=32)进行全外显子测序。
- 将CADD评分≥20且VarSome Clinical分类为可能致病或致病的变异定义为推测致病性胚系或体细胞变异(PPGV/PPSV)。
- 进一步分析癌症相关基因中的PPGV/PPSV、心血管风险基因中的PPGV,并鉴定与非洲血统相关的PPGV/PPSV。
主要发现
- 在16个癌症易感或已知癌症相关基因中鉴定出17个PPGV,仅WRN既往已知与NMTC易感相关。
- BRAFV600E是最常见的PPSV,在29例肿瘤中检出12例(41%)。
- 在死于NMTC的3例患者中,1例死于甲状腺乳头状癌/未分化甲状腺癌(PTC/ATC)的患者使作者推测PPGV ERCC4R799W可能增加PPSV TP53R273H获得的风险。
- 在18个心血管风险基因中鉴定出PPGV,其中SC5NA、GYG1、CBS、CFTR和SI的PPGV已知对心血管疾病具有因果和致病意义。
局限性
- 原文报告需进一步探索可能促进TP53肿瘤突变获得的PPGV和/或易感不良心血管事件的PPGV的临床影响。
- 原文报告需进一步探索可能因治疗所致心脏毒性而加重的不良心血管事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: African American (AA) thyroid cancer patients have worse prognoses than European Americans (EA), which has been attributed to both health care disparities and possible genetic differences. We investigated the impact of both germ line and somatic variants on clinical outcome in a cohort of AA nonmedullary thyroid cancer (NMTC) patients who had received therapeutic intervention from cancer centers. Methods: Whole-exome sequencing was performed on DNA from available blood/normal tissues (N = 37) and paired tumor samples (N = 32) collected from 37 and 29 AA NMTC patients, respectively. Variants with Combined Annotation Depletion Dependent (CADD) score of ≥20 and VarSome Clinical classification of likely pathogenic or pathogenic were classified as presumed pathogenic germ line or somatic variants (PPGVs/PPSVs). PPGVs/PPSVs in cancer-related genes and PPGVs in cardiovascular risk genes were further investigated, and PPGVs/PPSVs associated with African (AFR) ancestry were identified. Results: Among 17 PPGVs identified in 16 cancer predisposition or known cancer-related genes, only WRN was previously known to associate with NMTC predisposition. Among PPSVs, BRAFV600E was most the prevalent and detected in 12 of the 29 (41%) tumors. Examining PPGVs/PPSVs among three patients who died from NMTC, one patient who died from papillary thyroid carcinoma/anaplastic thyroid carcinoma (PTC/ATC) led us to speculate that the PPGV ERCC4R799W may have increased the risk of PPSV TP53R273H acquisition. Among PPGVs identified in 18 cardiovascular risk genes, PPGVs in SC5NA, GYG1, CBS, CFTR, and SI are known to have causal and pathogenic implications in cardiovascular disease. Conclusion: In this cohort, most AA-NMTC patients exhibit favorable outcomes after therapeutic intervention given at cancer centers, suggesting that health care disparity is the major contributor for worse prognoses among AA-NMTC patients. Nevertheless, the clinical impact of PPGVs that might facilitate the acquisition of TP53 tumor mutations, and/or PPGVs that predispose individuals to adverse cardiovascular events, which could be exacerbated by therapy-induced cardiotoxicity, needs to be further explored. Integrated analysis of PPGV/PPSV profiles among NMTC patients with different stages of disease may help to identify NMTC patients who require close monitoring or proactive intervention.
引用
- Hurst ZA, Liyanarachchi S, Brock P, et al. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer. Thyroid. 2024. PMID: 38062767. doi:10.1089/thy.2023.0487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。